PAPER Furukawa A, Oikawa S, Hasegawa-Ishii S, Chiba Y, Kawamura N, Takei S, Yoshikawa K, Hosokawa M, Kawanishi S, Shimada A
SEARCH RESULTS
330988 RESULTS
PAPER Schnabel J
Protein folding: The dark side of proteins.
Nature. 2010 Apr 8;464(7290):828-9. PubMed: 20376124PAPER Wisniewski T, Sigurdsson EM
Murine models of Alzheimer's disease and their use in developing immunotherapies.
Biochim Biophys Acta. 2010 Oct;1802(10):847-59. PubMed: 20471477Miguel RodrÃguez-Manotas on Toward structural elucidation of the gamma-secretase complex.
COMMENT The presenilin hypothesis should be explained taken into account the latest findings from the three-dimensional structure of secretase complex and the monomeric condition. If the water channels were, in fact, two distinct channels through which the same m
Deborah Blacker on NIH Calls for More (and Different) Research on Preventive Measures
COMMENT With regard to the big picture, I agree with John Breitner that RCTs have largely focused on treatment of established AD. A few have looked at MCI, but it has been defined at a high threshold, such that the likelihood of progression to dementia in a few y
Susan Resnick
NIABaltimore, United States
Cassondra Kowalski
Germany
Tau TAUY5
ANTIBODY polyclonal manufacturer Cat# AHB0351 immunogen = synthetic peptide, corresp. to aa residues 186-201 of human tau protein isoform 6 (GEPPKSGDRSG-pY-SSPG), conj. to KLH via an N-terminal cysteine residue liquid, purified Ig, PBS, azide detects both non-phos
Tau TAUY7
ANTIBODY polyclonal manufacturer Cat# AHB0381 immunogen = synthetic peptide, corresp. to aa residues 384-397 of human tau protein isoform 6 (AKTDHGAEIV-pY-KSP), conj. to KLH via an N-terminal cysteine residue liquid, purified Ig, PBS, azide detects both non-phosph